Guohai Shi
- Molecular Biology top 2%
- Cancer Research top 0.5%
- Pulmonary and Respiratory Medicine top 2%
- Oncology top 5%
- Surgery
- Topics
- Renal cell carcinoma treatment (49 papers)Ferroptosis and cancer prognosis (29 papers)Renal and related cancers (24 papers)
- Journals
- Nature CommunicationsSHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- ChinaUnited StatesAustria
In The Last Decade
Guohai Shi
100 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Molecular Biology 3.0k
- Cancer Research 2.5k
- Pulmonary and Respiratory Medicine 879
- Oncology 490
- Surgery 269
Countries citing papers authored by Guohai Shi
This map shows the geographic impact of Guohai Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guohai Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guohai Shi more than expected).
Fields of papers citing papers by Guohai Shi
This network shows the impact of papers produced by Guohai Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guohai Shi. The network helps show where Guohai Shi may publish in the future.
Co-authorship network of co-authors of Guohai Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Guohai Shi. A scholar is included among the top collaborators of Guohai Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guohai Shi. Guohai Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 56 | |
| 3 | 8 | |
| 4 | 1 | |
| 5 | 21 | |
| 6 | 3 | |
| 7 | 11 | |
| 8 | 18 | |
| 9 | 17 | |
| 10 | Review of Research on the Role of Irisin in Tumors | 1 |
| 11 | 40 | |
| 12 | 16 | |
| 13 | 46 | |
| 14 | 25 | |
| 15 | 59 | |
| 16 | 27 | |
| 17 | Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAsbreakdown → | 1644 |
| 18 | 1 | |
| 19 | 5 | |
| 20 | 1 |
About Guohai Shi
Guohai Shi is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 101 papers that have together received 3.8k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (49 papers), Ferroptosis and cancer prognosis (29 papers) and Renal and related cancers (24 papers). The work is most often cited by research in Cancer Research (2.5k citations), Molecular Biology (3.0k citations) and Pulmonary and Respiratory Medicine (879 citations). Guohai Shi has collaborated with scholars based in China, United States and Austria. Frequent co-authors include Qiupeng Zheng, Xianghuo He, Weijie Guo, Chunyang Bao, Shenglin Huang, Jie Chen, Dongbin Lyu, Bing Chen, Yanting Luo and Yan Li. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.